Sharif Tabebordbar is the founder of Kate Therapeutics. Kate Therapeutics has raised $51M in total funding. Latest round: Series A.
Sharif Tabebordbar is a co-founder of Kate Therapeutics, a biotechnology company focused on developing AAV-based gene therapies for genetically defined muscle and heart diseases. The company emerged from stealth in June 2023 with a $51 million Series A financing round.
Full founder directory · Investor directory · Company funding database · Fundraising library